Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Dexcom Inc
Nieuws
Dexcom Inc
DXCM
NAS
: DXCM
| ISIN: US2521311074
17/12/2025
65,75 USD
(-0,93%)
(-0,93%)
17/12/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
16 december 2025 ·
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM
· Persbericht
9 december 2025 ·
Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
· Persbericht
5 december 2025 ·
Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM
· Persbericht
2 december 2025 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom Lawsuit - DXCM
· Persbericht
25 november 2025 ·
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
· Persbericht
24 november 2025 ·
Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.
· Persbericht
22 november 2025 ·
DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
· Persbericht
21 november 2025 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM
· Persbericht
17 november 2025 ·
DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)
· Persbericht
14 november 2025 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM
· Persbericht
13 november 2025 ·
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
· Persbericht
11 november 2025 ·
Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately
· Persbericht
11 november 2025 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM
· Persbericht
7 november 2025 ·
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM
· Persbericht
15 juli 2025 ·
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
· Persbericht
13 september 2024 ·
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
· Persbericht
13 september 2024 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM
· Persbericht
12 september 2024 ·
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
· Persbericht
11 september 2024 ·
Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of October 21, 2024 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm
· Persbericht
10 september 2024 ·
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe